• 23andMe Has Report on APOL1- Related Kidney Disease

    Aug 25

    23andMe added a new Genetic Health Risk report on APOL1-related chronic kidney disease. This disease has a particular relevance for 23andMe customers with African ancestry. The Chronic Kidney Disease (APOL1-Related) Genetic Health report includes two variants in the APOL1 gene that can increase the risk of developing chronic kidney diseas...


  • 23andMe and GSK Start Clinical Trial

    Aug 11

    23andMe has been collaborating with GlaskoSmithKline (GSK) for two years (as of July of 2020). The goal of the collaboration is to drive the discovery of novel, genetically validated drug targets to bring new transformational medicine to patients. Studies show that treatments that have been validated with genetic data are twice as likely to su...


  • 23andMe Improved its G6PD Deficiency Report

    Jul 14

    23andMe has updated its G6PD Deficiency Genetic Health Risk Report. The update includes testing for an additional variant linked to G6PD deficiency, a condition that can lead to episodes of anemia. Two of the most common variants linked to G6PD Deficiency are V68M and S188F. Previously, 23andMe reported on just one of those variants, V68M. ...


  • Study About Parkinson’s Includes Data from 23andMe

    Jun 9

    A new study about Parkinson's Disease, that was published in the journal Nature Medicine, relied on data from more than four million 23andMe customers. The results of the study may help speed efforts to find drug targets for treating Parkinson's disease. Working with researchers at 23andMe, scientists at the Broad Institute of MIT and Harva...


  • 23andMe Published a New BRCA Study

    May 12

    23andMe announced that their new BRCA study was published in Scientific Reports and is titled “Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry”. 23andMe says that this study could help inform the on-going discussion around broader access to BRCA genetic testing. The study is co...


  • 23andMe is Doing a Genetic Study on COVID-19

    Apr 23

    Beginning this week, 23andMe hopes to enroll hundreds of thousands of 23andMe customers in the United States to participate in a study about COVID-19. The study will include both individuals who have and have not tested positive for the virus. Scientists can quickly look for genetic variants that are more common among research participant...


  • 23andMe Reported New Genetic Associations for Myopia

    Apr 16

    23andMe reported that a team of researchers discovered previously unknown genetic mechanisms that lead to myopia, or nearsightedness, including new associations with circadian rhythm. Led by scientists at King's College London, researchers from University College London, Kaiser Permanente, and 23andMe identified three ways that genetics pla...


  • New Genetic Association Identified for Heart Failure

    Mar 24

    23andMe announced that researchers at Johns Hopkins University have identified three genes associated with heart failure, a devastating condition that affects an estimated 23 million people worldwide. The study was originally published in the journal Nature Communications. The study offers researchers new insight into the underlying biology...


  • 23andMe Feature Automates Genetic Family Trees

    Mar 10

    23andMe has added a new feature called Family Tree. It will automatically start your tree based on your list of DNA Relatives. With a new algorithm, 23andMe's Family Tree predicts how you might be connected to your genetic relatives, so you don't have to start from scratch. According to a recent study conducted by 23andMe researchers, more ...


  • 23andMe Licenses Antibody it Developed to Almirall

    Feb 11

    Almirall, a leading global pharmaceutical company focused on medical dermatology, and 23andMe, a leading consumer genetics and research company, have signed an agreement allowing Almirall to license 23andMe's biospecific monoclonal antibody designed to block all three members of the IL-36 cytokine subfamily. IL-36 is part of the IL-1 cyto...